This protocol addresses the first-line management of mild bleeding at a visible or compressible site in patients with Glanzmann's thrombasthenia — a situation that calls for a targeted, site-specific approach.
First-line options include local measures applied directly to the bleeding site, or an antifibrinolytic agent used as monotherapy, depending on the clinical picture. The full protocol details which option to select, when to combine approaches, and what to apply at the site — those specifics are in the complete structured regimen.
DOI: 10.3324/haematol.2018.214239